Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Axsome Thera
(NQ:
AXSM
)
87.99
+0.88 (+1.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axsome Thera
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Expert Ratings for Axsome Therapeutics
August 30, 2022
Within the last quarter, Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings:
Via
Benzinga
HC Wainwright Boosts Price Target On This Stock By 167%, Plus B of A Securities Predicts $40 For This Online Travel Stock
August 30, 2022
HC Wainwright & Co. raised the price target for Rockwell Medical, Inc. (NASDAQ: RMTI) from $3 to $8. Rockwell Medical shares rose 0.7% to close at $1.42 on Monday.
Via
Benzinga
$1000 Invested In Axsome Therapeutics 5 Years Ago Would Be Worth This Much Today
August 29, 2022
Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 57.38% on an annualized basis producing an average annual return of 67.54%. Currently, Axsome Therapeutics has a...
Via
Benzinga
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
August 29, 2022
These names are benefitting from M&A, clinical data and promising regulatory actions.
Via
Investor's Business Daily
AXSOME THERAPEUTICS INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Axsome Therapeutics, Inc. - AXSM
August 26, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Boxed Warnings May Not Hinder This Depression Drug's Broad Market Penetration, Analyst Says
August 23, 2022
Via
Benzinga
Why Is Axsome Therapeutics (AXSM) Stock Up 30% Today?
August 19, 2022
Biopharmaceutical company AXSM stock is getting a huge lift from news the FDA has approved its depression treatment.
Via
InvestorPlace
AMC Entertainment Price Target Cut By This Analyst, Plus DA Davidson Predicts $318 For Estée Lauder
August 23, 2022
DA Davidson cut the price target for The Estée Lauder Companies Inc. (NYSE: EL) from $342 to $318. Estée Lauder shares fell 0.4% to $264.29 in pre-market trading.
Via
Benzinga
Netflix Price Target Cut By This Analyst, Plus Morgan Stanley Predicts $403 For McKesson
August 22, 2022
UBS cut the price target for Coupa Software Incorporated (NASDAQ: COUP) from $84 to $76. Coupa Software shares fell 4.9% to $64.44 in pre-market trading.
Via
Benzinga
Stocks That Made New Highs On Friday, Aug. 19
August 21, 2022
On Friday, in spite of the stock market being down, there were several stocks that actually made new highs.
Via
Talk Markets
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 19, 2022
Via
Benzinga
S&P 500 Down More Than 1%; Bed Bath & Beyond Shares Plummet
August 19, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 250 points on Friday.
Via
Benzinga
Axsome's Depression Candidate Scores FDA Nod, Stock Surges To 52-High
August 19, 2022
Via
Benzinga
Axsome Therapeutics: Q2 Earnings Insights
August 09, 2022
Axsome Therapeutics (NASDAQ:AXSM) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
August 22, 2022
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 19, 2022
Via
Benzinga
Axsome Therapeutics Rockets After Winning FDA Approval For A New Depression Drug
August 19, 2022
Axsome's drug targets a neurotransmitter believed to play a role in depression.
Via
Investor's Business Daily
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session
August 19, 2022
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday.
Via
Benzinga
How Is The Market Feeling About Axsome Therapeutics?
August 19, 2022
Axsome Therapeutics's (NASDAQ:AXSM) short percent of float has fallen 3.86% since its last report. The company recently reported that it has 5.75 million shares sold short, which...
Via
Benzinga
Nasdaq Dips 250 Points; Crude Oil Moves Higher
August 19, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 250 points on Friday.
Via
Benzinga
Here's How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Years
August 19, 2022
Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 52.74% on an annualized basis producing an average annual return of 64.23%. Currently, Axsome Therapeutics has a...
Via
Benzinga
General Motors, Foot Locker And Some Other Big Stocks Recording Gains On Friday
August 19, 2022
GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday.
Via
Benzinga
GCT Stock Alert: What Is Going on With GigaCloud Technology Today?
August 19, 2022
GigaCloud Technology (GCT) stock is continuing to rally on Friday after the Hong Kong-based fintech company launched its IPO yesterday.
Via
InvestorPlace
Why Is Volcon (VLCN) Stock Up 56% Today?
August 19, 2022
Volcon (VLCN) stock is rocketing higher on Friday after the EV company revealed massive pre-production orders for its Stag.
Via
InvestorPlace
Dow Falls Over 200 Points; Deere Earnings Miss Estimates
August 19, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 19, 2022
Via
Benzinga
Axsome Shares Shoot Higher As FDA Approves Major Depressive Disorder Candidate
August 19, 2022
The U.S. Food and Drug Administration (FDA) has approved Axsome Therapeutics’ (NASDAQ: AXSM) lead asset AUVELITY (dextromethorphan HBr -bupropion HCl) extended-release tablets for the treatment of...
Via
Benzinga
Covid Exposed A 'Brain Health Pandemic' — Here's How Biotech Stocks Like Biogen, Sage Therapeutics Could Help
August 11, 2022
Today's depression drugs don't fit many patients' needs. Biotech companies may change that.
Via
Investor's Business Daily
What 4 Analyst Ratings Have To Say About Axsome Therapeutics
August 10, 2022
Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.